The enzyme-mimicking activity of iron oxide based nanostructures has provided a significant advantage in developing advanced molecular sensors for biomedical and environmental applications. Herein, we introduce the horseradish peroxidase (HRP)-like activity of gold-loaded nanoporous ferric oxide nanocubes (AuNPFe2O3NC) for the development of a molecular sensor with enhanced electrocatalytic and colorimetric (naked eye) detection of autoantibodies. The results showed that Au-NPFe2O3NC exhibits enhanced peroxidase-like activity toward the catalytic oxidation of 3,3′,5,5′-tertamethylbenzidine (TMB) in the presence of H2O2 at room temperature (25 °C) and follows the typical Michaelis-Menten kinetics. The autoantibody sensor based on this intrinsic property of Au-NPFe2O3NC resulted in excellent detection sensitivity [limit of detection (LOD) = 0.08 U/mL] and reproducibility [percent relative standard deviation (% RSD) = <5% for n = 3] for analyzing p53-specific autoantibodies using electrochemical and colorimetric (naked eye) readouts. The clinical applicability of the sensor has been tested in detecting p53-specific autoantibody in plasma obtained from patients with epithelial ovarian cancer high-grade serous subtype (EOCHGS, number of samples = 2) and controls (benign, number of samples = 2). As Au-NPFe2O3NC possess high peroxidase-like activity for the oxidation of TMB in the presence of H2O2 [TMB is a common chromogenic substrate for HRP in enzyme-linked immunosorbent assays (ELISAs)], we envisage that our assay could find a wide range of application in developing ELISA-based sensing approaches in the fields of medicine (i.e., detection of other biomarkers the same as p53 autoantibody), biotechnology, and environmental sciences. ELISAs), we envisage that our assay could find a wide range of application in developing ELISA based sensing approaches in the field of medicine (i.e. detection of other biomarkers same as p53 autoantibody), biotechnology and environmental sciences.
Introduction
Iron oxide (IO) nanostructures have widely been used in a variety of biomedical applications, such as tissue engineering, magnetic resonance imaging, hyperthermia, drug and gene targeting, isolation and separation of proteins or cells from samples, and in-vivo cell tracking. 1, 2 The paramagnetic properties of IO nanoparticles also allows for contactless sample preparation and handling using the emerging technology of micromagnetofluidics. 3 In recent years, it has been demonstrated that IO based nanoparticles (NPs) possess an intrinsic horseradish peroxidase (HRP)-mimicking activity towards the oxidation of common chromogenic substances such as 3,3ˊ,5,5ˊ-tertamethylbenzidine (TMB), di-azoaminobenzene, and o-phenylenediamine , which have widely been used in catalytic decomposition of hydrogen peroxides or developing non-enzymatic glucose sensors. 4 7, 8, 9, 10, 11 Similar to IO based NPs, other nanomaterials such as AuNPs, Eu 2 O 2 SNPs, CuONPs, coppercreatinine complex, AgX (X= Cl, Br, I), polyoxometalates, PtNPs, carbon nanotubes and nanodots have also been reported to exhibit peroxidase-like activity. 6, 12, 13, 14, 15, 16, 17, 18, 19 The use of these peroxidase-mimetic nanomaterials for developing biosensors is highly attractive due to several reasons. First, unlike natural peroxidase (i.e., HRP) they are stable towards protease digestion or denaturation, and their structure, morphology and function are not affected by environmental stresses. 20 Second, they are relatively easy and inexpensive to prepare and highly suitable for benchtop storage and handling. Despite these advantages,
most of these materials demonstrate their highest peroxidase-like activity at higher temperature (40 -45 °C) , which limits their applications in disease specific biomolecules detection at room temperature. Therefore, design and synthesis of NPs with enhanced peroxidase-mimetics activity at room temperature are highly desirable.
Recently, we have synthesized a new class of gold-loaded superparamagnetic ferric oxide nanocube (Au-NPFe 2 O 3 NC). 21 This Au-NPFe 2 O 3 NC exhibits multiple functionalities.
First, it shows enhanced catalytic activity towards the common electroactive molecules (i.e., hexaammineruthenium(III) chloride, (Ru(NH 3 ) 6 Cl 3 )). 22 Second, highly porous framework of gold loaded Fe 2 O 3 nanocubes allows for the direct adsorption of large amount of target DNA, RNA or protein via gold-DNA/RNA/Proteins affinity interactions. 23, 24, 25, 26 Third, as these nanocubes are paramagnetic, they can be used as dispersible capture vehicles to isolate the circulating biomarkers in body fluids (i.e., they can be dispersed into the sample and bind to the analytes of interest). 21 As the capture event of the target analytes of interest temporally and spatially separated from the electrochemical measurement, this alleviates biofouling issues of the electrode. The Au-NPFe 2 O 3 NC nanocubes also provide a mean to reduce the biological noises associated with adsorption of non-specific species present in the body fluids via magnetic enrichment, separation, and purification steps. yet to be demonstrated. In this paper, we studied this peroxidase-like activity for the development of a proof-of-concept molecular sensor for detecting circulating autoantibodies in serum or plasma samples.
Circulating autoantibodies that are elicited in responses to tumor-associated antigen (TAA) are emerging biomarkers for the early detection of cancer, as they are produced by the patient's immune system long (several months or years) before the onset of the clinical symptoms of diseases. 27, 28, 29 The direct quantification of TAAs in clinical samples possess severe challenges due to their low abundance and associated difficulties in identifying minor structural modification or mutation. In contrast, serum autoantibodies are relatively more stable (i.e., longer half-lives due to limited proteolysis and clearance) and present as large quantities in clinical samples and therefore they have been used as circulating reporters for the early or pre-clinical detection of various cancers including ovarian, lung, and breast cancer. 30, 31, 32, 33, 34 It is also important to note that, with the progression of the cancer (stages), the amount of autoantibody (produced) compared to that of TAAs is highly significant and readily detectable with the conventional detection techniques. 35 Most of the widely used methods for serum autoantibody detection are mainly based on ELISA or protein arrays that employ HRP conjugated protein specific secondary antibodies to read the target autoantibody. 31, 32, 33, 34, 35, 36, 37 Only patients with epithelial ovarian cancer high-grade serous subtype (n = 2) and benign controls (n = 2) were included in this study. 
Peroxidase
In this equation, V o is the rate of substrate conversion to product, V max is the maximum rate of conversion, which is attained when the active (catalytic) sites on the enzyme are saturated with substrate, [S] is the substrate concentration, and K m is the Michaelis-Menten constant (denotes the affinity of enzyme for the substrate), which is equivalent to the substrate concentration at the conversion rate is half of V max . The rearrangement of Michaelis-Menten equation gives the Lineweaver-Burk equation, 40 which was used to determine enzyme kinetics terms K m and V max .
Colorimetric and amperometric detection of serum p53 autoantibody. The SPCE-XTR was kept at room temperature for 1 h and washed with PBS. 5.0 μL (100 ng/mL) p53 antigen was incubated onto the electrode surface for 40 min. After the incubation, the electrode surface was washed with PBS three times followed by further incubation with 1% BSA that produced a blue-coloured charge-transfer complex of parent TMB (diamine) and TMB oxidised product (diimine), which could be used for qualitative (naked-eye) evaluation.
Second, this blue-coloured complex turned yellow after the addition of an acid. 4 21, 22 Bright field TEM and HAADF-STEM images for this materials clearly showed that they possessed highly porous structure ( Figure S1in Supporting Information). SEM images in Figure S2 (Supporting Information) resulted that the Au content is well distributed over the entire particles. The peaks in the wide-angle XRD pattern are assignable to Au, α-Fe 2 O 3 , and γ- Among all studied pH values, pH 2.5 resulted the highest responses both in colorimetry and amperometric readouts. As the iron could be leached from the nanocubes in the solution pH of <3, 7 we selected pH 3.5 as the optimal pH for conducting subsequent experiments in our study. To optimize the amount of nanocubes in our assay, 5 μL of designated concentrations (i.e., 2.5 (0.5 μg/μL), 5 (0.5 μg/μL), 10, (2 μg/μL) and 20 μg (4 μg/μL)) of nanocubes were used. As can be seen in Figure S4b1 The experiments were carried out using 5 μg nanocubes in a reaction volume of 60 µL (0.2 M NaAc buffer, pH 3.5) at room temperature. The kinetic parameters were estimated by initial rate method. 7, 45 The absorbance data were converted to corresponding concentration by the Beer-Lambert Law using the value of ɛ = 39,000 M Figure 2 ), 40 and compared with that for previously reported peroxidase-mimetic nanoparticles (Table S1 in Supporting Information). K m is an indicator of enzyme affinity towards its substrate and a lower K m indicates the stronger affinity between enzymes and substrates. The apparent K m value for Au-NPFe 2 O 3 NC with TMB was lower than HRP, suggesting that the nanocubes has higher affinity with TMB in compare to the HRP. 4 Moreover, K m value with both TMB and H 2 O 2 is also higher than that of non-porous Fe 3 O 4 NPs. 4 The enhanced peroxidase-activity of our nanocubes at room temperature can be related to the highly porous ferric oxide moiety with high surface area Colorimetric and amperometric detection of autoantibody. Our assay for the detection of p53-specific autoantibody using peroxidase-mimetic Au-NPFe 2 O 3 NC nanocubes is schematically represented in Figure 3 . Here, p53 antigen was used to selectively recognise and capture the p53-specific autoantibody present in serum and plasma samples. In this proof-of-concept assay, we have chosen p53 autoantibody, because mutation in TP53
proteins is an early indicator of cancer and also found to be present in almost 80% of all carcinogenesis. 34 In response to the expression and mutation of this protein, corresponding amount of p53-tumor antigen-associated autoantibodies (TAAb) are generated, which has been considered as a potential early diagnosis biomarker for ovarian (type-II) cancer. 9 In our assay, first, neuravidin-modified screen-printed carbon electrode (SPCE) was modified with biotinylated p53 antigen through standard biotin-avidin chemistry. Bovine serum albumin (BSA) was then used to block the unreacted sites to reduce non-specific bindings of biomolecules followed by the incubation of serum or plasma samples containing target p53
autoantibody. As protein has the strong affinity towards gold surface, we functionalized Au- To evaluate the assay specificity and functionality, we performed our assay in both p53 positive and negative samples. Diluted serum samples from commercial ELISA kit (ELISA-kit, Dianova GmbH, Germany) containing p53 autoantibody was used as a positive sample and serum samples without p53 autoantibody was taken as negative sample. 52 The p53 autoantibody concentration in diluted human plasma sample is 14 U/mL, where 1.0 U represents the p53 binding activity of 100 µL undiluted calibrator. We found that, positive samples containing 7.0 U/mL (1:1 Dilution) of p53 autoantibody gave an intense blue colour, while stoichiometric amount of negative samples remained colourless. As can be seen in Figure 4a , a 10-times higher absorbance (abs@452 nm) was observed for positive sample compared to that of negative sample (0.616 versus 0.0526). Chronoamperometric measurement of positive sample was found to be 16-times higher than that of negative one To evaluate the sensitivity of our assay, a series of diluted positive samples obtained via serial dilution (1:1 to 1:80; 7 U/mL to 0.0875 U/mL) was tested. We observed an increasing trend in both the absorbance and current response with the increasing concentration of target autoantibody (Figure 4 ). This is because, the higher amount of target p53 autoantibody could bound an increasing amount of nanocatalysts on the electrode surface which subsequently enhance the nanocatalysts mediated oxidation of TMB (in presence of H 2 O 2 ) system. As shown in Figure 5a , the colorimetric responses increase linearly with the increasing concentration of serum samples, and the linear regression equation was estimated to be y = 0.04741x -0.0226, with the correlation coefficient (r 2 ) of 0.9684. The detection limit (LOD) was estimated by corresponding signal-to-noise ratio of 2.5, 52 and was found to be 0.12 U/mL for the colorimetric readout. On the other hand, the linear regression equation nanocatalysts is sensitive and specific enough to detect autoantibody in p53 positive serum samples. Moreover, LOD for both readout systems are better than that of the conventional p53-ELISA kit (0.08 versus ~0.3 U/mL). 52 These LODs are also better than that of a recently reported Halotag-fusion protein modification based electrochemical platform (0.08 versus 0.34 U/mL). 38 Therefore, our methods can detect much lower concentration of p53 autoantibody than above reported methods. It is also important to note that the sensitivity of our recently reported HRP-based method 21 is slightly better than that of the current method (i.e., 0.02 versus 0.08 U/mL) than that of the current method. However, our current method avoids the use of expensive HRP-based reaction system.
We further checked the applicability of our novel platform for the analysis of complex human plasma samples. The plasma samples were obtained from women with epithelial ovarian cancer high-grade serous subtype (stage I and III, P3 and P4 respectively) and controls (P1 and P2) (benign). Ovarian cancer in one of the leading causes of cancer-related death of woman from gynaecologic malignancy. 9 It has been reported that, in response to the overexpression or mutation of protein (TP53) in ovarian cancers, p53-antigen specific autoantibodies are generated. 53 TP53 mutation occurs early in high grade ovarian cancer and strongly attendant with the p53 autoantibodies. 35 Thus, development of an early diagnosis platform for ovarian cancers via p53-autoantibody analysis can potentially decrease the disease burden as well as increase the overall survival. In this study, all clinical samples were diluted (1:100) prior performing the assay. As projected, both colorimetric and electrochemical methods response were higher in stage III patients (P4) sample than stage I (P3) ( Figure 6 ). However, the assay can also differentiate the stage I response from the two non-cancerous healthy controls. Both of these healthy controls (P1 and P2) produced negligible signal suggesting the absence of p53 autoantibody. These clinical data showed a very good inter-assay reproducibility (RSD <5%, for n = 3) for the analysis of differential expression pattern of p53 autoantibodies in different stages of ovarian cancers.
The naked-eye discrimination of the autoantibodies described here hold huge potential for the development of a user-friendly and inexpensive bioassay in resource-limited settings, where sophisticated scientific equipment is unavailable. In particular, this approach can be exploited as a rapid first-pass screening (yes/no) tool to detect clinically relevant autoantibodies in large population followed by more accurate and sensitive quantification of autoantibody via amperometric readout. used to develop a new proof-of-concept platform for autoantibody detection body fluids samples using both colorimetric and electrochemical readout. This platform successfully detected the p53 autoantibodies in diluted serum and a small cohort of patients' plasma samples with high sensitivity and specificity.
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The Supporting Information is available free of charge on the ACS Publications website at DOI: Table S1, detailed and (c) are the corresponding photos for the naked eye evaluation and i-t curves respectively). 
